Investors – Forte Medical

Forte Medical case study within Imperial College Innovation paper

30th July2023/in AMR, analysis, British business, business, diagnosis, diligence, Disruption, Enterprise, Evidence, export, FemTech, Finance, health, healthcare, infection control, innovation, Investment, Investors, medicine, MedTech, midstream, patient safety, pregnancy, research, sample, SME, specimen, testing, Uncategorized, urine, UTI /by Giovanna

Commissioned by Lord Sainsbury and authored by Professor James Moore and Yunus Kutlu, Imperial College has published a report on innovation adoption in the UK and wh

at prevents successful adoption of impactful innovation. Forte Medical features as the only case study and outlines issues with silo systems, a disconnect between procurement and fincance all topped off with vested interests from labs and leadership.

The Peezy Midstream case study outlines how adoption of preventative devices and practice are resisted, leading to missed opportunities for improved patient health, prompt diagnoses, prevention and huge cost savings across the patient pathway.

Read all about it here. – see Page 29 and Appendix 2

Imperial Business School: a MedTech to Market Journey

15th November2022/in AMR, analysis, antenatal, British business, business, diagnosis, Enterprise, Evidence, export, FemTech, Finance, health, healthcare, infection control, innovation, Investment, Investors, medicine, MedTech, midstream, patient safety, pregnancy, pregnant, research, sample, screening, Series A, SME, specimen, Uncategorized, urine, USA, UTI /by Giovanna

Giovanna’s annual talk to the Imperial Business School took place last week; here we share the presentation Deck. Had she known in 2002 what she knows now, it would have taken a third of the time to create three specimen collection products and a springboard to global reach. She and Dr Vincent Forte are beyond proud of what they have achieved. 202210_ForteMedical_HealthTech_Commercialisation_Journey

Informa: Giovanna Forte one of 30 Rising Leaders in Life Sciences

21st April2022/in British business, business, Enterprise, FemTech, Finance, healthcare, innovation, Investment, Investors /by Giovanna

We are delighted to share the Informa list of 30 Rising Leaders in Life Sciences, which features Forte Medical’s very own CEO Giovanna Forte. Click here for the full story.

To No 10 for the LS Industrial Strategy Reception

5th December2018/in British business, FemTech, Finance, innovation, Investment, Investors, MedTech, research /by Forte Medical

Today, Forte Medical’s Chief Executive Giovanna Forte attended the Life Sciences Industrial Strategy reception at No 10 Downing Street – creating the foundation for brilliant innovation and MedTech

Forte Medical: Series A investment growth round is open

20th June2018/in British business, business, Disruption, Enterprise, FemTech, Finance, health, healthcare, innovation, Investment, Investors, medicine, Series A, SME, Uncategorised /by Forte Medical

This week saw the launch of Forte Medical’s Series A investment round for growth, export and new product development. Seeking £3.5m, the company is engaging with prospective investment partners who can attract investors with an interest in evidenced, disruptive diagnostic medical devices with digital potential.

Institutional, corporate or personal investors who can assist the business long term are seen as the most promising and attractive partners. For more information, contact our CEO Giovanna Forte.

WEB MAP

GET IN TOUCH

Forte Medical

59-60 Russell Square
London WC1B 4HP

hello@forte-medical.com
https://forte-medical.com

SOCIAL MEDIA

Latest from Twitter

After so many years we can truly say there is a better and more hygienic way to collect #urine samples. The #PeezyMidstream is for all patients that are required to give a sample - even the elderly and our younger patients. Try the Peezy Midstream - up to 100% accurate. pic.twitter.com/CJ6AXk1wHc

About 2 years ago from @peezymidstream's Twitter via Buffer

Catching unwanted conditions early, such as #UTI's is paramount for the long term health of Mum and baby. The #PeezyMidstream has been a long awaited addition to a #midwife's daily testing routine saving them time and discomfort and worry for parents. #urine pic.twitter.com/pG3714eQQg

About 2 years ago from @peezymidstream's Twitter via Buffer

Helping healthcare practitioners to remove doubt on the #urine samples they've taken. Currently 1 in 4 samples are contaminated due to the way it has been taken. These samples lead to a waste of time and money for both the #NHS and the patient. #patientcare #uti #urology #peezy

About 2 years ago from @peezymidstream's Twitter via Buffer

#Barts #NHS Hospital tested using the Peezy and the results were notable. Reducing contaminated samples by 21.5% (from 23 to 1.5%) - the knock on effect impacted cost and time savings to the hospital. buff.ly/3DJ5qrh #urine #urology #Peezy #costsavings #timesavings

About 2 years ago from @peezymidstream's Twitter via Buffer

The problem with prescribing antibiotics unnecessarily is that it may not cure the problem! Using the #PeezyMidstream are up to 100% reliable to get the right diagnosis and then the right treatment - first time every time. #NHS #urine #urology #patientfirst pic.twitter.com/f0coFaUlAy

About 2 years ago from @peezymidstream's Twitter via Buffer